132 related articles for article (PubMed ID: 22801283)
1. Hepatorenal repercussions of alcoholic exposure in a rat model: a dose-dependent study of metformin intervention.
Borole KD; Bodhankar SL; Dawane JS; Kanwal JK
Iran Biomed J; 2012; 16(2):101-6. PubMed ID: 22801283
[TBL] [Abstract][Full Text] [Related]
2. Oral metformin-ascorbic acid co-administration ameliorates alcohol-induced hepatotoxicity in rats.
Adeneye AA; Benebo AS
Nig Q J Hosp Med; 2007; 17(4):155-9. PubMed ID: 18320763
[TBL] [Abstract][Full Text] [Related]
3. Involvement of insulin resistance in the protective effect of metformin against alcoholic liver injury.
Zhu Z; Jiang Z; Zhou J; Zhou D; Wang W; Zhao C; Zhen Z; Nanji AA
Alcohol Clin Exp Res; 2014 Jun; 38(6):1510-9. PubMed ID: 24797033
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic effect of mangiferin in combination with oral hypoglycemic agents metformin and gliclazide.
Sekar V; Mani S; Malarvizhi R; Nithya P; Vasanthi HR
Phytomedicine; 2019 Jun; 59():152901. PubMed ID: 30981189
[TBL] [Abstract][Full Text] [Related]
5. Scutellaria baicalensis enhances the anti-diabetic activity of metformin in streptozotocin-induced diabetic Wistar rats.
Waisundara VY; Hsu A; Huang D; Tan BK
Am J Chin Med; 2008; 36(3):517-40. PubMed ID: 18543386
[TBL] [Abstract][Full Text] [Related]
6. Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease.
Assy N; Grozovski M; Bersudsky I; Szvalb S; Hussein O
World J Gastroenterol; 2006 Jul; 12(27):4369-76. PubMed ID: 16865780
[TBL] [Abstract][Full Text] [Related]
7. Antihyperglycaemic and anti-oxidant properties of Andrographis paniculata in normal and diabetic rats.
Zhang XF; Tan BK
Clin Exp Pharmacol Physiol; 2000; 27(5-6):358-63. PubMed ID: 10831236
[TBL] [Abstract][Full Text] [Related]
8. Alpha-ketoglutarate mediated hepatoprotection against alcohol induced toxicity:
Mehra L; Rawat H; Jaimini A; Tyagi A; Mittal G
Drug Chem Toxicol; 2020 Sep; 43(5):546-551. PubMed ID: 31094237
[TBL] [Abstract][Full Text] [Related]
9. Citrus fruit-derived flavonoid naringenin and the expression of hepatic organic cation transporter 1 protein in diabetic rats treated with metformin.
Mato Mofo EP; Essop MF; Owira PMO
Basic Clin Pharmacol Toxicol; 2020 Sep; 127(3):211-220. PubMed ID: 32180335
[TBL] [Abstract][Full Text] [Related]
10. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats.
Zhang XF; Tan BK
Acta Pharmacol Sin; 2000 Dec; 21(12):1157-64. PubMed ID: 11603293
[TBL] [Abstract][Full Text] [Related]
11. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
[TBL] [Abstract][Full Text] [Related]
12. [Effect of metformin on the formation of hepatic fibrosis in type 2 diabetic rats].
Qiang GF; Zhang L; Xuan Q; Yang XY; Shi LL; Zhang HA; Chen BN; Du GH
Yao Xue Xue Bao; 2010 Jun; 45(6):801-6. PubMed ID: 20939194
[TBL] [Abstract][Full Text] [Related]
13. Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats.
Zhai L; Gu J; Yang D; Wang W; Ye S
J Diabetes Res; 2015; 2015():231825. PubMed ID: 26075281
[TBL] [Abstract][Full Text] [Related]
14. Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin.
Saad ZA; Khodeer DM; Zaitone SA; Ahmed AAM; Moustafa YM
Life Sci; 2020 Jul; 253():117725. PubMed ID: 32348835
[TBL] [Abstract][Full Text] [Related]
15. Polyherbal mixture ameliorates hyperglycemia, hyperlipidemia and histopathological changes of pancreas, kidney and liver in a rat model of type 1 diabetes.
Madić V; Petrović A; Jušković M; Jugović D; Djordjević L; Stojanović G; Vasiljević P
J Ethnopharmacol; 2021 Jan; 265():113210. PubMed ID: 32795501
[TBL] [Abstract][Full Text] [Related]
16. Antidiabetic and antihyperlipidemic activities of a novel polyherbal formulation in high fat diet/streptozotocin induced diabetic rat model.
Subhasree N; Kamella A; Kaliappan I; Agrawal A; Dubey GP
Indian J Pharmacol; 2015; 47(5):509-13. PubMed ID: 26600639
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-stabilized selenium nanoparticles alleviate cardio-hepatic damage in type 2 diabetes mellitus model via regulation of caspase, Bax/Bcl-2, and Fas/FasL-pathway.
Mohamed AA; Khater SI; Hamed Arisha A; Metwally MMM; Mostafa-Hedeab G; El-Shetry ES
Gene; 2021 Feb; 768():145288. PubMed ID: 33181259
[TBL] [Abstract][Full Text] [Related]
18. Metoprolol decreases the plasma exposure of metformin via the induction of liver, kidney and muscle uptake in rats.
Ma YR; Shi AX; Qin HY; Zhang T; Wu YF; Zhang GQ; Wu XA
Biopharm Drug Dispos; 2016 Dec; 37(9):511-521. PubMed ID: 27662517
[TBL] [Abstract][Full Text] [Related]
19. Metformin increases hepatic leptin receptor and decreases steatosis in mice.
Tang X; Li J; Xiang W; Cui Y; Xie B; Wang X; Xu Z; Gan L
J Endocrinol; 2016 Aug; 230(2):227-37. PubMed ID: 27288055
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 inflammasome drives inflammation in high fructose fed diabetic rat liver: Effect of resveratrol and metformin.
Rai RC; Bagul PK; Banerjee SK
Life Sci; 2020 Jul; 253():117727. PubMed ID: 32371063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
